X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Pet Cancer Therapeutics Companies

This report lists the top Pet Cancer Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Pet Cancer Therapeutics industry.

Home Market Analysis Healthcare Research Animal Health Research Animal Medicine Research Animal Therapeutics and Diagnostics Industry Companies

Pet Cancer Therapeutics Top Companies

  1. Boehringer Ingelheim GmbH (Merial)

  2. Zoetis

  3. Elanco (VetDC)

  4. ELIAS Animal Health

  5. Vivesto AB (AdvaVet, Inc)

*Disclaimer: Top companies sorted in no particular order

Pet Cancer Therapeutics Market Major Players

Pet Cancer Therapeutics Market Concentration

Pet Cancer Therapeutics Market Concentration

Pet Cancer Therapeutics Company List

                              • AB Science

                              • Vivesto AB (AdvaVet, Inc)

                              • Boehringer Ingelheim GmbH (Merial)

                              • Elanco (VetDC)

                              • ELIAS Animal Health

                              • Karyopharm Therapeutics, Inc.

                              • Dechra Pharmaceuticals PLC (Anivive Lifesciences)

                              • Torigen Pharmaceuticals Inc.

                              • Elekta

                              • Virbac

                              • Norbrook

                              • Zoetis


                          Specific to Pet Cancer Therapeutics Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Pet Cancer Therapeutics Market Report Snapshots

                          Pet Cancer Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)